Italia - Kiitaliano - Ministero della Salute

vetoquinol italia srl - calcio ione, colecalciferolo, cianocobalamina - calcio ione - 50 mg; colecalciferolo - 1.25 mui; cianocobalamina - 25 mg - multivitamins and calcium

Italia - Kiitaliano - Ministero della Salute

bayer ag - cyprosulfamide; isoxaflutole; - sospensione concentrata - 20.3 g; 20.3 g i valori indicati sono per 100 g di prodotto. - isoxaflutole; 20,3%; (240; g/l); cyprosulfamide; (antidoto; agronomico); 20,3%; (240; g/l) - diserbante

Italia - Kiitaliano - Ministero della Salute

bayer ag - thiencarbazone; isoxaflutole; cyprosulfamide; - sospensione concentrata - 7.6 %; 19.1 %; 12.7 % i valori indicati sono per 100 g di prodotto. - isoxaflutole; 19,1%; (225; g/l); thiencarbazone-methyl; 7,6%; (90; g/l); cyprosulfamide; (antidoto; agronomico); 12,7%; (150; g/l) - diserbante

Italia - Kiitaliano - Ministero della Salute

bayer ag - flupyradifurone; - concentrato solubile - 200.0 g/l i valori indicati sono per 100 g di prodotto. - flupyradifurone; 17,1%; (200; g/l) - insetticida

Uswisi - Kiitaliano - Swissmedic (Swiss Agency for Therapeutic Products)

axapharm ag - ibuprofenum - compresse rivestite con film - ibuprofenum 400 mg, ibuprofenum lysinum 684 mg, cellulosum microcristallinum, copovidonum, carboxymethylamylum natricum a magnesii stearas, Überzug: poly(alcohol vinylicus), talcum, macrogolum 4000, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, natrii hydrogenocarbonas, e 171, pro compresso obducto corresp. natrium 2.746 mg. - analgesico - synthetika

Italia - Kiitaliano - Ministero della Salute

bayer ag - concentrato emulsionabile - spiroxamina; pura; 30,6%; (300; g/l); protioconazolo; puro; 16,3%; (160; g/l) - fungicidi

Umoja wa Ulaya - Kiitaliano - EMA (European Medicines Agency)

mylan pharmaceuticals limited - teriflunomide - sclerosi multipla recidivante-remittente - immunosoppressori - teriflunomide mylan is indicated for the treatment of adult patients and paediatric patients aged 10 years and older (body weight > 40 kg) with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 of the smpc for important information on the population for which efficacy has been established).

Umoja wa Ulaya - Kiitaliano - EMA (European Medicines Agency)

accord healthcare s.l.u. - teriflunomide - sclerosi multipla recidivante-remittente - immunosoppressori selettivi immunosoppressori - teriflunomide accord is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).

Uswisi - Kiitaliano - Swissmedic (Swiss Agency for Therapeutic Products)

zambon svizzera sa - ibuprofenum - granulare - ibuprofenum 400 mg ut ibuprofenum argininum, argininum, natrii hydrogenocarbonas, saccharum 1770 mg, aromatica (cola-limone), saccharinum natricum, aspartamum 60 mg, ad granulatum pro charta 3 g corresp. natrium 57 mg. - antiflogistico, analgesico, antipiretico - synthetika

Umoja wa Ulaya - Kiitaliano - EMA (European Medicines Agency)

sun pharmaceutical industries europe b.v. - sitagliptin fumarate, metformin hydrochloride - diabete mellito, tipo 2 - farmaci usati nel diabete - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride sun is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride sun is indicated in combination with a sulphonylurea (i. , triplice terapia di associazione) in aggiunta alla dieta e all'esercizio fisico in pazienti non adeguatamente controllati il loro dosaggio massimo tollerato di metformina ed una sulfonilurea. sitagliptin/metformin hydrochloride sun is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. sitagliptin/metformin hydrochloride sun is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.